Summary of most frequent adverse events with WHO grade 3 or 4 for patients with relapsed or refractory peripheral T-cell lymphoma treated by various salvage therapy.
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
官方服务：
资源简介：
Summary of most frequent adverse events with WHO grade 3 or 4 for patients with relapsed or refractory peripheral T-cell lymphoma treated by various salvage therapy.
创建时间：
2016-10-12
